 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval# A; w5 Y! \* c+ y5 M7 g
" a7 H/ e r1 [EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX./ X4 h" g9 ]: H( w
8 S7 `" c5 t! ~% b+ zBY THE EDMONTON JOURNAL FEBRUARY 16, 20079 _0 q4 v1 d" _; j3 C' c0 `7 {
1 g4 q( i! C( I
4 v L8 I4 L5 E" w$ T( C+ v N
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
2 X, q; E% f) w" H3 }1 f) z& U) p4 N, M% B) c6 f f+ N9 f1 G* B
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."1 h' m3 u) L$ R; E! }: L
8 ]- h8 v( @ Q u6 C5 xThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.+ ~7 y, E1 \& ?# u1 x
, O: ?5 \& d! s$ [8 PIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.+ z$ x5 F1 w' R8 p4 U
6 R2 F! ?8 j8 @3 OIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
* v. D3 Q- e* J4 a- x% K1 H: I+ o( l: J$ v- l; u. Z
"As a scientist, it's one of the highlights of my CAREER," Shan said.
/ B0 P$ H1 G) j" v" n6 y7 S& L6 S1 X! Z
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention.". q, i- @1 v7 X3 B6 z6 f7 g
$ s: X% G! r: Y" V% g1 j* A
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
+ l/ ^- s+ o3 \1 r6 \, g; i2 W* R& i& Q
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.- X d5 H0 T4 X
0 j0 k/ R: ?! H$ {. w4 I% Z4 w3 CThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.1 L/ k& V4 _+ Z1 |, f
1 e# j& @* F$ e e* z- }" y6 w3 b
, \: e3 r8 n6 qhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|